1. Home
  2. WLYB vs TWST Comparison

WLYB vs TWST Comparison

Compare WLYB & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLYB

John Wiley & Sons Inc.

HOLD

Current Price

$36.71

Market Cap

1.9B

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$44.91

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLYB
TWST
Founded
1807
2013
Country
United States
United States
Employees
5200
N/A
Industry
Books
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
3.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WLYB
TWST
Price
$36.71
$44.91
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$48.75
AVG Volume (30 Days)
230.0
928.8K
Earning Date
03-05-2026
05-04-2026
Dividend Yield
3.89%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
$0.02
$18.91
Revenue Next Year
$2.32
$15.07
P/E Ratio
$15.27
N/A
Revenue Growth
N/A
20.32
52 Week Low
$29.16
$23.30
52 Week High
$45.16
$57.88

Technical Indicators

Market Signals
Indicator
WLYB
TWST
Relative Strength Index (RSI) 65.39 47.30
Support Level $36.20 $41.69
Resistance Level $38.63 $45.76
Average True Range (ATR) 0.33 2.63
MACD 0.60 -0.49
Stochastic Oscillator 94.35 35.17

Price Performance

Historical Comparison
WLYB
TWST

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: